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Abstract
The current field of posterior pole and retinal imaging of the human eye has expanded into detailed analyses of
the macula, retinal periphery, individual retinal layers, vitreoretinal interface, imaging of the choroid and the optic
nerve head. The challenge in retinal imaging is the enduring pursuit of deeper penetration into tissues, increased
resolution to the cellular level, and interpretation of observations. How much deeper can we go and with what
resolution and reproducibility? These are fundamental questions for experts in search of novel imaging modalities.
New discoveries may resolve existing controversies, but inevitably stimulate new questions. Emerging technologies
in retinal imaging include adaptive optics retinal imaging and optical coherence tomography-based retinal angiography.
In this review, the focus of our discussion will be the discrepancy between the findings (interpretation) of one imaging
technology that do not agree or are not even found with a complementary technology. If a clearly seen abnormality is
present with one technology but absent in another, what are the possible explanations? Following is a summary of key
concepts of retinal and optic nerve imaging modalities and current controversies regarding their interpretation and/or
limitations.
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Background
The two most common imaging modalities utilized to
detect macular edema due to various etiologies include
fluorescein angiography (FA) and optical coherence
tomography (OCT). Fluorescein angiography for clinical
use was first described by Novotny and Alvis in 1961
[1]. The retinal vessels and leakage are detected by
photographing the retina after injecting sodium fluorescein
into the subject’s peripheral veins. Since that time, and with
improvements, it has been routinely used in the clinical
practice to analyze retinal (and choroidal) vascular diseases.
Traditional camera-based systems use blue light to illu-
minate the retina and detect fluorescein emission. En-
hancements to this have surfaced in recent years through
the use of confocal scanning laser ophthalmoscopy (cSLO)
that emits a very precise laser wavelength designed to
achieve peak emission from the fluorescein. There is an
improved signal-to-noise ratio and less out-of-focus and
scattered light when using cSLO [2].
Since its introduction, optical coherence tomography
has rapidly assumed an important and indispensable role
as a noninvasive diagnostic and monitoring imaging mo-
dality in numerous diseases of the retina and the choroid
[3]. Optical coherence produces cross-sectional images
of optical reflectivity in the retina using optical interfer-
ometry to resolve the distances of reflective structures
within tissue [4]. New generations of this technology, in-
cluding spectral-domain and swept source OCT, have
enabled even faster acquisition and reduction in the
signal-to-noise ratio [5]. The introduction of OCT angi-
ography and increasing experience with interpreting
OCT images has reduced the need for FA and its associ-
ated intravenous injection.
Both FA and high-definition OCT imaging are used to
illustrate different pathologic aspects. FA identifies the
anatomical location and pattern of vascular leakage, and
is generally a qualitative and functional study, whereas
OCT allows a morphological and quantitative assessment
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of pathology such as macular edema (ME) by producing
two or three-dimensional images of the retinal tissue.
While both FA and OCT are used extensively to detect
and characterize the same pathology, in some instances
OCT and FA may yield discrepant findings in the same
patient [6, 7]. In this review we will highlight some of
these discrepancies and their underlying etiologies in
different retinal and choroidal diseases.
Review
Controversies in detection of macular diseases
Age-related macular degeneration
Age-related macular degeneration (AMD) is the leading
cause of severe visual impairment in elderly people in
the developed world; however, the management of this
condition has been radically altered by the introduction
of anti-vascular endothelial growth factor therapy [8].
The visual prognosis in cases of neovascular AMD is vari-
able and depends upon the location, composition, and size
of the neovascular membrane. FA is still a mainstay in diag-
nosing neovascular AMD and providing information about
the membrane size from the area of visible leakage.
Today, spectral domain OCT (SD-OCT) and non-
invasive fundus autofluorescence imaging can provide
additional anatomical information beyond the FA, includ-
ing visualization of the layer of the retina and choroid in-
volved with the neovascular membrane [9, 10]. OCT has
gained popularity for the diagnosis and management of
AMD because of its non-invasive nature and ability to pro-
duce cross-sectional images of the neurosensory retina, the
subretinal space, retinal pigment epithelium, Bruch mem-
brane and inner choroid. Mokwa et al. studied the agree-
ment and activity of choroidal neovascularization (CNV)
between spectral-domain OCT and FA in AMD [10]. They
defined activity on FA if classic or occult CNV leakage was
detected and on SDOCT if diffuse or cystoid intraretinal
fluid or subretinal fluid accumulation was seen. The agree-
ment between SD-OCT and FA regarding the activity of
CNV lesions in their study was found in 79 %. They felt
that when the two technologies did not agree, it was ex-
plained by the fact that FA and SD-OCT imaging provided
different information about retinal pathology. The FA is
used to obtain information about the perfusion and the
growth of new vessels as well as the integrity of the blood-
retinal barrier. OCT provides detailed information about
anatomical and pathological changes in the layers of the
retina, such as the presence of cystoid spaces. Cystoid
spaces on SD-OCT may not necessarily indicate active
CNV but may represent structural defects resulting from
chronic disease. In these cases, the disagreement between
SD-OCT and FA will be evident because fluorescein leak-
age on FA will not be noted [11].
On the other hand, CNV activity may be seen on FA
and not be apparent on SD-OCT; this occurs if only
intraretinal cystoid spaces and subretinal fluid accumula-
tion are considered to represent CNV activity on SD-OCT.
Other findings were found to indicate CNV activity, includ-
ing intraretinal hyper-reflective flecks and fluid accumula-
tion in the sub-RPE space, such as serous components of a
pigment epithelial detachment (PED) [10].
Kozak et al. also reported a discrepancy in the detec-
tion of macular edema in various retinovascular diseases
including AMD. They observed in 1,272 eyes that 94.97 %
had the finding of ME or subretinal fluid confirmed by both
techniques. There were 3.86 % of eyes in whom the FA
showed dye leakage in the macular area and OCT demon-
strated a normal foveal contour. Conversely, in 1.17 %,
OCT showed intraretinal and subretinal fluid, which was
not revealed by FA [6]. Most recently, Wilde et al. reported
diagnosing 278 eyes with choroidal neovascularization
(CNV) using SD-OCT and 231 diagnosed with FA [12]. In
their cohort, they found a total of 47 false positive cases
with SD-OCT (16.9 %) and reported sensitivity and spe-
cificity of SD-OCT alone for detecting CNV 100 % and
80.8 %, respectively. They concluded that SD-OCT was
highly sensitive for detecting newly presenting neovascular
AMD; however, in comparison to the reference standard
of non-stereoscopic fundus FA in a specialized clinic, it
did not seem accurate enough to replace FA in the diag-
nosis of wet AMD [12]. A report by Moult et al. using
swept-source OCT angiography (OCTA) in exudative
AMD demonstrates visualization of CNV in 16 of 19 eyes
with previously confirmed exudative AMD [13].
The use of OCT has increased dramatically during the
past decade, whereas use of FA had declined considerably
[14]. Despite the high sensitivity of SD-OCT to identify
CNV and CNV activity, many believe that FA still has a role
in the initial diagnosis and staging of eyes with CNV.
FA allows visualization of retinal vasculature and neovascular
retinal/choroidal proliferations in addition to dynamic
features such as perfusion and exudation [13, 14].
The American Academy of Ophthalmology AMD
Preferred Practice Pattern advocates the use of intra-
venous fundus FA when a patient complains of new
metamorphopsia or has unexplained blurred vision; it
can also be used when the clinical examination reveals
elevation of the RPE or the retina, subretinal blood,
hard exudates, or subretinal fibrosis. Fluorescein angiog-
raphy is also indicated in the following situations: to detect
the presence of and determine the extent, type, size, and
location of CNV; to detect persistent or recurrent CNV
following treatment and to assist in determining the cause
of visual loss that is not explained by the clinical examin-
ation [15, 16]. The use of FA and/or OCT is determined in
part by the treatment strategy used for a particular patient.
As stated in a recent editorial, both modalities are needed
to comprehensively monitor patients with neovascular
AMD [16]. The retina and imaging community is excited
Shoughy and Kozak Eye and Vision  (2016) 3:26 Page 2 of 9
to see if improvements in OCT angiography, which
currently lacks the component of dye leakage, will be
the technology that will entirely eliminate intravenous
fluorescein angiography.
Uveitis
Macular edema is one of the most common vision threat-
ening complications of uveitis and can affect patients with
different types of ocular inflammation [17]. Cystoid macular
edema (CME), the most common structural type of uveitic
macular edema (UME), was noted in 33 % of all uveitis pa-
tients [18, 19]. If the media is clear, the presence of macular
edema can be detected clinically. However, biomicroscopic
evaluation of macular edema may be difficult when the
amount of the fluid and the anatomical changes are
minimal or there is an inflammatory reaction in the
eye. Fundus FA is the conventional method for the as-
sessment of UME by visualizing the area of leakage. It
is particularly valuable to assess the retinal vascular integrity
and to characterize the area of the foveal avascular zone.
OCT imaging is non-invasive and directly assesses macular
thickness and the presence of intraretinal cysts [17].
Several studies evaluated the agreement between FA
and OCT when diagnosing macular edema in patients
with uveitis. Kempen et al. found that OCTand FA offered
only moderate agreement regarding macular edema status
in uveitis cases. The discrepancy noted in some cases was
attributed to the difference in what FA and OCT measure.
Macular leakage detected by FA and macular thickness as
measured by OCT are caused by the same pathology but
have different impacts on our diagnosis and treatment
[20]. Leakage may be noted on FA in the absence of
detectable macular thickening on OCT, which may occur
in either a severely damaged macula that is atrophic and
thin but has ongoing inflammatory leakage, a macula
where leakage has recently begun and thickening has not
yet occurred, a macula distorted by epiretinal membrane
but not thickened, or a macula where leakage is balanced
by physiologic outflow of fluid from the macula providing
a steady state without thickening. On the other hand,
macular thickening may occur in the absence of leakage
on FA. This may occur for reasons other than current
vascular leakage like failure to clear osmotically active
molecules from the retina or dysfunction of the retinal
pigment epithelial pump, and might take some time to
clear after leakage is no longer present [20]. They also
found that in most cases of uveitis, OCT seemed the most
appropriate first test to evaluate the macula, unless some
other specific indication for FA exists (e.g., suspected
vasculitis, vascular closure, neovascularization or optic
nerve leakage, or for evaluation of a white dot syndrome).
This was based on the observed superiority of OCT in
obtaining gradable images, along with its lower cost,
safety, better tolerance and non-invasive nature. They
suggested that obtaining the second test after a negative
result on the first seems justified when detection of macular
edema would alter management [20]. Ossewaarde-van
Norel et al. reported on the discrepancy between FA
and OCT findings in 46 % of uveitic eyes [21]. They
found FA leakage in the absence of macular edema on
OCT predominantly in eyes with birdshot chorioretino-
pathy, which also exhibited lower central retinal thick-
ness values compared with the other uveitis entities.
On the other hand, they found macular edema on OCT
in the absence of FA leakage in association with inter-
mediate uveitis. Interestingly, they also found that the
consistency between FA and OCT was noted frequently
in patients with active uveitis; OCT positive findings in
absence of FA leakage was common in eyes with in-
active uveitis [21]. Similar to the study by Kozak et al.
[3] the OCT technology used in the two reports was
time-domain.
While OCT seemed like the most appropriate first test
to evaluate the macula in patients with uveitis, FA was
found more sensitive in detecting CNV secondary to in-
flammatory conditions such as multifocal choroiditis
[18]. Another limitation of OCT imaging is the lack of
identification of vasculitis or vascular occlusions in cases
of uveitis. Kotsolis et al. demonstrated that FA was more
reliable in documenting actively proliferating neovascu-
larization than either time- or spectral-domain OCT in
patients with uveitis [18]. They recommend that FA
should be used in the evaluation of eyes suspected of
having active CNV in MFC and in any other diseases
exhibiting inflammatory-related neovascularization of
the macula. They found clear evidence of actively proliferat-
ing neovascularization on OCT in only 53.8 % of the eyes
that clearly demonstrated CNV by FA. They explained this
discrepancy by accumulation of blood and proteinaceous
exudate in the subretinal space in the inflammatory-related
CNV. The inflammatory debris appear to produce a homo-
geneous cellular mass, which fills the sub-neurosensory
space surrounding the CNV. Consequently, this highly re-
flective, serosanguineous material gives a false impression
of attachment between the RPE and the retina with OCT
imaging and the absence of the usual silent reflectance indi-
cative of detachment. Other possible explanations for this
discrepancy include the possibility that the OCT image did
not register areas that were noted to be leaking during the
FA; and leakage with FA may not always be associated with
subretinal or intraretinal bulk flow of fluid [22, 23].
Diabetic macular edema
Prior to the development and widespread use of OCT
technology in ophthalmology, clinical examination with
contact lens and FA were employed commonly in diabetic
patients to evaluate, plan treatment, and to monitor
diabetic macular edema (DME). Because clinical detection
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of macular edema may be possible only if severe macular
involvement has already developed, it is then mandatory
to image the macula in suspicious cases since early diag-
nosis of macular edema leads to more effective treatment.
Both imaging modalities, FA and OCT, are complemen-
tary investigations, each revealing different aspects of the
pathophysiologic aspects of DME [24]. Fundus FA dem-
onstrates the area of dye leakage, while OCT quantifies
macular edema. Spectral OCT has some advantages
over FA in the evaluation of DME, including shorter
image acquisition time, lack of systemic risks, and reprodu-
cible quantitative reporting of retinal thickness measure-
ments. In patients with DME, minute structures including
microexudates can be mapped and quantified [25].
In a comparison of FA and OCT for detection of ME
in diabetic patients, Ozdek et al. found that the sensitivity
of OCT was higher than that of FA, especially for the
cystoid pattern of ME [26]. Accordingly, OCT can facilitate
treatment decision and follow-up of diabetic patients,
which is especially important in the early stages of diabetic
maculopathy when the structural changes are not yet
evident with slit-lamp biomicroscopy or FA. Soliman et al.
found that early morphologic changes in diabetic ME may
be seen better with FA than with OCT [27]. The combined
data from both OCT and fluorescein angiography may
provide a clearer understanding of the anatomic and
physiologic characteristics of clinically significant diabetic
macular edema [28]. These studies have used time-domain
OCT technology. Macular thickness measurements in
patients with diabetic macular edema differ significantly
in magnitude between TD-OCT and SD-OCT systems
[29]. This is primarily due to the different definition of
outer retinal border, and whether RPE is or is not included
in the measurement. At the same time, repeatability of ret-
inal thickness measurements with spectral-domain OCT
has been shown to be comparable to the time-domain
OCT [30–32].
Some reports, however, favor SD-OCT over fundus FA
because of sensitivity. Jittpoonkuson et al. reported that
SD-OCT gave earlier macular edema diagnosis than FA
in 3.53 % of eyes in their study and that residual macular
edema at follow-up visits was missed by FA in 1.18 % of
eyes [33]. In a study by Brar et al. [34] spectral-domain
OCT technology has shown presence of cysts in petal-
loid type of FA leakage. Diffuse non-cystoid angiographic
macular edema showed microcysts on SD-OCT, but was
more commonly associated with thickening or distortion
of the retinal layers without cyst formation. It is, thus,
possible that scanning laser SD-OCT allows visualization
of cystic structures not seen on fluorescein angiography.
Myopic choroidal neovascularization
Pathologic myopia, a major cause of visual impairment and
legal blindness, is associated with progressive elongation of
the globe. It may be accompanied by degenerative changes
in the sclera, choroid, Bruch's membrane, retinal pigment
epithelium (RPE), and neurosensory retina. Choroidal
neovascularization at the macula is the most common
vision-threatening complication of pathologic myopia
[35]. The diagnosis of new-onset myopic CNV may be
difficult to establish purely by fundus examination for
several reasons, including choroidal pallor, posterior pole
staphyloma, pigmentary changes, lacquer cracks, and chor-
ioretinal atrophic lesions [36]. Both FA and SD-OCT are
important diagnostic tools for myopic CNV. Fundus FA
measures area of dye leakage and OCT demonstrates the
amount of macular edema or outer retina disturbance.
Leveziel et al. found no agreement regarding signs of
active CNV between OCT and FA. Exudative features of
myopic CNV were more obvious on FA (82 %) than on
SD OCT (48.6 %). They suggested that fluorescein angi-
ography should be performed when new-onset myopic
CNV was suspected. One possible explanation of the little
information that can be obtained from OCT in cases of
myopic CNV is the less exudative behavior of the new
vessels associated with myopic CNV compared with those
associated with neovascular AMD [37]. Another import-
ant factor less frequently mentioned in studies is sampling
error in OCT scanning in highly myopic eyes, especially
those with posterior staphylomas. Sampling error with in-
correct placement of B-scans can significantly reduce the
sensitivity of CNV detection. This is less common with
the aerial view on fluorescein angiograms.
Despite proclaimed superiority of FA in cases of myopic
CNV, Milani et al. found that, on the basis of FA alone, ac-
tive myopic CNV can be misdiagnosed and they suggested
the use of SD-OCT in combination with FA [38]. In a re-
cent study, Chhablani et al. found that repeatability and
reproducibility for the diagnosis of myopic CNV was bet-
ter with FA compared with SD-OCT; however, SD-OCT
was a comparatively better tool for ruling out the presence
of myopic CNV [39].
Gaucher et al. described the OCT finding of a character-
istic bulge of the macular retina, RPE, and choroid within
the concavity of the moderate posterior staphyloma in
myopic eyes. In their study, FA showed atrophic changes
in the macular retinal pigment epithelium (RPE) in all
eyes, combined with focal points of leakage in some eyes.
The dome-shaped macula often is associated with RPE
atrophic changes and foveal retinal detachment, which
may explain the visual impairment in those eyes [40].
Pseudophakic cystoid macular edema
Pseudophakic cystoid macular edema (pseudophakic CME,
also termed “Irvine-Gass syndrome”) is a swelling of the
fovea due to fluid accumulation occurring a few weeks to
months after cataract surgery. It is one of the most import-
ant causes of visual impairment after cataract surgery. The
Shoughy and Kozak Eye and Vision  (2016) 3:26 Page 4 of 9
prevalence of pseudophakic CME varies from study to
study depending on the method used in its detection.
By using fluorescein angiography, a prevalence of up to
20 % has been reported. However, with inclusion of loss
of vision as a requirement to establish the diagnosis,
the prevalence of pseudophakic CME was found to be
only 2 %. Its incidence has also decreased with less in-
vasive cataract surgery [41].
Fundus FA in cases of pseudophakic CME can reveal
capillary dilatation and leakage from small perifoveal capil-
laries in the early phase of the angiogram. In later phases,
pooling in the outer plexiform layer results in the classic
perifoveal ‘petaloid’ staining pattern in addition to staining
of the optic nerve due to capillary leakage [42]. In cases of
pseudophakic CME, OCT can reveal the cystic spaces in
the outer nuclear layer of the central macula to enable
measurement of the macular edema. FA has been con-
sidered the gold standard for the diagnosis of pseudo-
phakic CME.
In cases of difficult venous access, oral fluorescein
administration is an alternative for obtaining a retinal
angiogram. Barteselli et al. found that oral FA had better
sensitivity compared with spectral-domain OCT for detec-
tion of pseudophakic CME [7]. The general consensus,
however, is that OCT is now the first method of choice
because of its non-invasive nature and ability to evaluate
and follow macular edema after cataract surgery. Com-
pared to fundus FA, measurement of the macular thick-
ness with OCT may provide better correlation with visual
acuity than FA grading [41, 42]. Spectral-domain optical
coherence tomography has been shown to detect retinal
findings, including photoreceptor inner segment/outer
segment junction (ellipsoid zone) abnormalities that are
correlated with visual acuity changes in treated patients
with Irvine-Gass syndrome [43].
Central serous chorioretinopathy
Central serous chorioretinopathy (CSCR) is characterized
by one or more serous detachments of the neurosensory
retina, commonly associated with retinal pigment epithe-
lium (RPE) detachments. The diagnosis of CSCR is mainly
based on clinical diagnosis but may be aided by FA and
OCT. Fluorescein angiography classically shows the leak-
age of dye from the choroid through a focal RPE defect
and its pooling in the subretinal space in acute CSCR.
Alternatively, OCT is used to quantify the amount and ex-
tent of the subretinal fluid, demonstrate thickening of the
neural retina and is commonly used for monitoring during
the follow-up and also for diagnosing the changes in the
neurosensory retina [44–46].
Fluorescein angiography is essential for the identification
of the leakage site for appropriate treatment with laser
photocoagulation while OCT should be used for follow-up
and evaluations of retinal thickness. On the other hand,
SD-OCT can be crucial in detecting small amounts of fluid
in chronic CSCR where the signal from depigmented RPE
can make it difficult to discern such fluid. It is also useful in
detecting CNV associated with CSCR [47].
OCT-based angiography is an emerging in vivo imaging
modality that images retinal vessels and their filling without
the use of intravenous dye injection. It captures physio-
logical and pathological blood vessels at different layers of
the retina by separating static/tissue from motion/blood
flow signals [48]. The detection of CNV in CSCR using
OCT-based angiography was recently reported in a
pilot study. Choroidal neovascularization was diagnosed
in 8 of 27 eyes (30 %) with CSCR based on FA imaging
analysis. Optical coherence tomography angiography
and corresponding OCT B-scans detected 100 % (8 of 8) of
these CNV lesions and correctly excluded 100 % (19 of 19)
of eyes with CSCR without CNV. Both sensitivity and spe-
cificity reached 100 % [48]. Additionally, a recent study by
Maftouhi et al. has shown that OCT angiography allowed
for the detection of CNV in chronic CSCR that is not
visible with other imaging techniques such as indocyanine
green angiography [49].
Controversies in retinal nerve fiber layer, optic nerve and
ganglion cell imaging
Imaging for glaucoma has been a topic of intense re-
search, and has gained a prime position in the manage-
ment of patients with glaucomatous optic neuropathy.
Disc photographs have been considered the gold standard
for documenting the optic nerve appearance. The limita-
tions of photographs are the lack of quantitative data to
demonstrate progression and the inability to provide early
detection of glaucoma. Photography of the retinal nerve
fiber layer (RNFL) has been proposed as a tool for detect-
ing glaucoma. However, it was fraught with issues in de-
veloping the images to demonstrate the RNFL and has not
evolved much in the digital age. Regardless, the ability to
see the RNFL is important in assessing the amount of
axonal loss due to ganglion cell death [50, 51]. Initial OCT
images had limitations in seeing the RNFL, so scanning
laser polarimetry was more popular for a little while
[52, 53]. Simultaneous with the development of the
scanning laser polarimetry (SLP) and OCT was the use
of confocal scanning laser ophthalmoscopy (SLO) [54].
As the SLO, OCT and polarimetry were each used to
image the RNFL, the initial winner was the nerve fiber
analysis with polarimetry. The algorithms and normative
database enhanced the usability of the instrument [55].
Polarimetry is sensitive to corneal birefringence and the
average polarization did not always match a patient with
the scans [56]. OCT seems to be less affected by these
properties, so it most likely provides more accurate RNFL
thickness data and is not prone to spurious birefringence
readings. The issues in obtaining useful RNFL scans then
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turned to the normal anatomy and the orientation of the
RNFL radiating out of the disc. For instance, a myopic
patient may have a significant tilt, with a RNFL pattern
that differs from a hyperope. This tilt moves the peaks a
few clock hours temporally, resulting in an “out of synch
peak” in place of the classic RNFL peak at the 6 and 12
position [57]. Thus, the RNFL normative data does not
accommodate the variation induced by tilt. This can really
only be picked up by three dimensional imaging or MRI
[58]. A small crowed disc would have a large bundle
exiting the disc. Many of the “artifacts” in RNFL mea-
surements are most likely due to the lack of adjust-
ments for normal RNFL anatomical variation. Another
factor is the size of the circle used to determine the
peaks of the RNFL (the TSNIT plot). If it is small and
close to the rim, we are less likely to see the effects of
RNFL bundle loss due to bundle loss. The problem
with the larger circle is the relationship to possible disc
tilt. If there is a large tilt and the scan is away from the
nerve, it may have a larger “out of synch” peak [59].
Optic nerve photos provide images of the cup-to-disc
in single plane image or stereo-images. Even amongst
experts the cup appearance did not always match the
level of visual field damage. Methods for detecting focal
rim changes have included the “ISNT” rule [60]. Studies
validating this rule showed moderate sensitivity but low
specificity [61]. Nerve imaging devices do not seem to
be much better in detecting damage than photographs.
The Heidelberg Retinal Tomogram (HRT) has various
modes for analyzing the rim and determining the likeli-
hood of glaucoma. Another method is the Moorfields
Regression Analysis (MRA). The MRA and the ISNT
rule have been evaluated in their ability to detect glaucoma.
There seems to be some evidence that the sensitivity and
specificity using the HRT are good at detecting glaucoma
[62]. The OCT was also evaluated for its ability using the
ISNT rule and was not found to have the sensitivity or spe-
cificity of either photos or HRT from prior studies [63, 64].
This is likely related to how OCT defines the cup. The way
the cup is measured and defined has been evolving with
OCT and the methods for determining the neural retinal
rim (NRR) are improving. Initially, the cup-to-disc from the
Stratus OCT did correlate well with photos, direct evalu-
ation of the disc or HRT. OCT was the outlier [65]. The
reference for the disc has been changed and incorporates
the tilt of the disc and variants in the slope of the disc into
the overall cup-to-disc assessment. The end of Bruch’s
membrane has been set as a reference below the disc
margin in most machines. The real refinements are how
the cup is determined beyond that. The internal limiting
membrane and the shortest arc length or distance from the
end of the RPE become the point set for the cup [66, 67].
This has greatly improved the ability to see the cup in a
similar ratio to what is seen clinically. The cup-to-disc,
however, is still not 100 % specific or sensitive, so attention
is still paid to both the RNFL and ganglion cells to deter-
mine the damage from glaucoma.
For many years, many have agreed that ganglion cell
loss seems to be the source of optic cupping and RNFL
loss due to glaucoma. Because the macula gives the
impression of having an abundance of ganglion cells,
this was the location of initial efforts at looking for
glaucoma-induced cell loss. The first generations of
OCT did not have the resolution to discriminate the
ganglion cell layer very well [68]. With the SD-OCTs
there has been much progress in looking at the ganglion
cell layer in glaucoma. It is now equivalent to imaging the
RNFL and ONH in evaluating glaucoma [69]. Asymmetry
has been shown to be a sensitive indicator for early glau-
coma [70]. Because the central portion of the visual field
is affected from the macular ganglion cell loss, structural
and function correlation needs to shift toward using the
more central part of the visual field [71].
Diabetic retinopathy has been considered primarily a
retinal microvascular disorder caused by the direct effects
of hyperglycemia and by the metabolic pathways it activates
[72]. However, some recent studies have demonstrated that
thinning of the inner retina may develop in patients with
diabetes, even before visible vascular signs of diabetic retin-
opathy [72–74]. The SD-OCT may represent an indispens-
able tool for identifying early signs of neurodegeneration in
diabetic patients, which may require neuroprotective mea-
sures [75]. Such findings cannot be obtained using fluores-
cein angiography.
Emerging technologies
Adaptive optics is a relatively new tool that makes it
possible for the ophthalmologist to evaluate the retina at
a cellular level. Adaptive optics technology aims to correct
the ocular aberrations and enhance performance of the
optical system [76]. In addition to the axial resolution pro-
vided by the spectral-domain optical coherence tomog-
raphy, adaptive optics provides diffraction-limited lateral
resolution by correction of ocular aberrations [77]. The
lateral resolution enables visualization of the photorecep-
tors, blood vessels, RPE, lamina cribrosa, RNFL and details
of the optic nerve head [77, 78]. However, normative
databases need to be developed for different popula-
tions as a reference for disease states [76]. Furthermore,
the reproducibility of the obtained images will need to
be confirmed before the full application of this technol-
ogy in the clinic [79].
Optical coherence tomography angiography is a new,
non-invasive imaging system that generates volumetric
data of retinal and choroidal layers. It has the ability to
show both structural and blood flow information. It allows
the visualization of retinal microvasculature by detecting
intravascular blood flow, using a split-spectrum amplitude-
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decorrelation angiography (SSADA) algorithm, without any
dye injection [80]. OCT angiography has been investigated
in various ocular diseases, including diabetic retinop-
athy, age related macular degeneration, retinal vascular
occlusions, polypoidal choroidal vasculopathy, macular
degeneration, macular telangiectasia type 2, choroideremia,
sickle cell disease, central serous chorioretinopathy, CNV
in myopia and peripapillary retinal perfusion in glaucoma
[80–85]. OCT angiography has several compelling charac-
teristics including its noninvasive nature. It can be acquired
in a few seconds, compared to several minutes for FA. The
3D imaging allows for depth resolution of pathology and
separation of individual vascular layers for evaluation [86].
Its current limitations include a relatively small field of
view, inability to show leakage, and tendency for image
artifacts [80].
Conclusion
In conclusion, FA and OCT are complementary investiga-
tions. OCT provides detailed imaging of anatomical retinal
layers, allows detection of microstructural changes, and
helps perform quantitative assessment during follow up. FA
is used to evaluate retinal vascular perfusion and the
integrity of the inner blood-retinal barrier. Therefore,
the use of either or both imaging modalities is advisable
for the most accurate diagnosis and the proper manage-
ment of retinal diseases.
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